Show simple item record

A multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action.

dc.contributor.authorZhang, Jing-Jing
dc.contributor.authorMuenzner, Julienne K
dc.contributor.authorAbu El Maaty, Mohamed A
dc.contributor.authorKarge, Bianka
dc.contributor.authorSchobert, Rainer
dc.contributor.authorWölfl, Stefan
dc.contributor.authorOtt, Ingo
dc.date.accessioned2018-03-08T10:20:32Z
dc.date.available2018-03-08T10:20:32Z
dc.date.issued2016-08-16
dc.identifier.citationA multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action. 2016, 45 (33):13161-8 Dalton Transen
dc.identifier.issn1477-9234
dc.identifier.pmid27334935
dc.identifier.doi10.1039/c6dt02025a
dc.identifier.urihttp://hdl.handle.net/10033/621315
dc.description.abstractA rhodium(i) and a ruthenium(ii) complex with a caffeine derived N-heterocyclic carbene (NHC) ligand were biologically investigated as organometallic conjugates consisting of a metal center and a naturally occurring moiety. While the ruthenium(ii) complex was largely inactive, the rhodium(i) NHC complex displayed selective cytotoxicity and significant anti-metastatic and in vivo anti-vascular activities and acted as both a mammalian and an E. coli thioredoxin reductase inhibitor. In HCT-116 cells it increased the reactive oxygen species level, leading to DNA damage, and it induced cell cycle arrest, decreased the mitochondrial membrane potential, and triggered apoptosis. This rhodium(i) NHC derivative thus represents a multi-target compound with promising anti-cancer potential.
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshAnimalsen
dc.subject.meshApoptosisen
dc.subject.meshBacteriaen
dc.subject.meshCaffeineen
dc.subject.meshCell Cycleen
dc.subject.meshCell Line, Tumoren
dc.subject.meshCell Survivalen
dc.subject.meshChick Embryoen
dc.subject.meshChorioallantoic Membraneen
dc.subject.meshCoordination Complexesen
dc.subject.meshDNA Damageen
dc.subject.meshHumansen
dc.subject.meshMembrane Potential, Mitochondrialen
dc.subject.meshMethaneen
dc.subject.meshReactive Oxygen Speciesen
dc.subject.meshRhodiumen
dc.subject.meshWound Healingen
dc.titleA multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action.en
dc.typeArticleen
dc.contributor.departmentHelmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.en
dc.identifier.journalDalton transactions (Cambridge, England : 2003)en
refterms.dateFOA2018-06-12T23:52:16Z
html.description.abstractA rhodium(i) and a ruthenium(ii) complex with a caffeine derived N-heterocyclic carbene (NHC) ligand were biologically investigated as organometallic conjugates consisting of a metal center and a naturally occurring moiety. While the ruthenium(ii) complex was largely inactive, the rhodium(i) NHC complex displayed selective cytotoxicity and significant anti-metastatic and in vivo anti-vascular activities and acted as both a mammalian and an E. coli thioredoxin reductase inhibitor. In HCT-116 cells it increased the reactive oxygen species level, leading to DNA damage, and it induced cell cycle arrest, decreased the mitochondrial membrane potential, and triggered apoptosis. This rhodium(i) NHC derivative thus represents a multi-target compound with promising anti-cancer potential.


Files in this item

Thumbnail
Name:
Zhang et al.pdf
Size:
1.047Mb
Format:
PDF
Description:
Open Access article
Download

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/